Location of brain lesions predicts conversion of clinically isolated syndromes to multiple sclerosis
暂无分享,去创建一个
Maria Assunta Rocca | Massimo Filippi | Marco Battaglini | Christian Enzinger | Frederik Barkhof | Olga Ciccarelli | Alex Rovira | Martina Absinta | M. Battaglini | O. Ciccarelli | F. Barkhof | M. Filippi | M. Rocca | M. Absinta | À. Rovira | C. Enzinger | A. Giorgio | R. V. van Schijndel | D. Chard | C. Gasperini | M. Tintoré | J. Frederiksen | Alessandro De Leucio | Declan Chard | Ronald van Schijndel | Nicola De Stefano | Claudio Gasperini | Antonio Giorgio | Mar Tintoré | Alessandro De Leucio | Jette Frederiksen | N. de Stefano | Alessandro De Leucio
[1] M. Battaglini,et al. Voxel-based assessment of differences in damage and distribution of white matter lesions between patients with primary progressive and relapsing-remitting multiple sclerosis. , 2008, Archives of neurology.
[2] Marco Rovaris,et al. Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study , 2001, The Lancet.
[3] F Fazekas,et al. Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial , 2009, The Lancet.
[4] F. Barkhof,et al. Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis , 1996, Annals of neurology.
[5] P M Matthews,et al. Spatial mapping of T2 and gadolinium-enhancing T1 lesion volumes in multiple sclerosis: evidence for distinct mechanisms of lesion genesis? , 1999, Brain : a journal of neurology.
[6] AJ Thompson,et al. Brain lesion location and clinical status 20 years after a diagnosis of clinically isolated syndrome suggestive of multiple sclerosis , 2012, Multiple sclerosis.
[7] Thomas E. Nichols,et al. Nonparametric permutation tests for functional neuroimaging: A primer with examples , 2002, Human brain mapping.
[8] M. Jenkinson. Non-linear registration aka Spatial normalisation , 2007 .
[9] M. Battaglini,et al. T2 lesion location really matters: a 10 year follow-up study in primary progressive multiple sclerosis , 2010, Journal of Neurology, Neurosurgery & Psychiatry.
[10] Mark W. Woolrich,et al. Advances in functional and structural MR image analysis and implementation as FSL , 2004, NeuroImage.
[11] A Giorgio,et al. Imaging distribution and frequency of cortical lesions in patients with multiple sclerosis , 2010, Neurology.
[12] J. Stockman,et al. Effect of early versus delayed interferon beta-1b treatment on disability after a first clinical event suggestive of multiple sclerosis: a 3-year follow-up analysis of the BENEFIT study , 2009 .
[13] David H. Miller,et al. Clinically isolated syndromes , 2012, The Lancet Neurology.
[14] P. Matthews,et al. Imaging of axonal damage in multiple sclerosis: Spatial distribution of magnetic resonance imaging lesions , 1997, Annals of neurology.
[15] M. Battaglini,et al. T2 lesion location really matters: a 10 year follow-up study in primary progressive multiple sclerosis , 2010, Journal of Neurology, Neurosurgery & Psychiatry.
[16] H P Hartung,et al. Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes , 2006, Neurology.
[17] Joaquín Goñi,et al. Brain pathways of verbal working memory A lesion–function correlation study , 2009, NeuroImage.
[18] F. Barkhof,et al. MRI criteria for MS in patients with clinically isolated syndromes , 2010, Neurology.
[19] Pablo Villoslada,et al. Mapping the brain pathways of declarative verbal memory: Evidence from white matter lesions in the living human brain , 2008, NeuroImage.
[20] S Ropele,et al. Lesion probability mapping to explain clinical deficits and cognitive performance in multiple sclerosis , 2011, Multiple sclerosis.
[21] Stephen M. Smith,et al. Threshold-free cluster enhancement: Addressing problems of smoothing, threshold dependence and localisation in cluster inference , 2009, NeuroImage.
[22] Moses Rodriguez,et al. Distinct Patterns of Multiple Sclerosis Pathology Indicates Heterogeneity in Pathogenesis , 1996, Brain pathology.
[23] F. Barkhof,et al. Genetic Correlations of Brain Lesion Distribution in Multiple Sclerosis: An Exploratory Study , 2011, American Journal of Neuroradiology.
[24] M. Jenkinson,et al. Non-linear optimisation FMRIB Technial Report TR 07 JA 1 , 2007 .
[25] A. Thompson,et al. Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis. , 2008, Brain : a journal of neurology.
[26] J. De Keyser,et al. Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes , 2006, Neurology.
[27] J H Simon,et al. Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group. , 2000, The New England journal of medicine.
[28] Melvin Greer,et al. Multiple sclerosis risk after optic neuritis: final optic neuritis treatment trial follow-up. , 2008, Archives of neurology.
[29] J. Ranjeva,et al. Cognitive impairment at the onset of multiple sclerosis: relationship to lesion location , 2011, Multiple sclerosis.
[30] Ludwig Kappos,et al. Effect of early versus delayed interferon beta-1b treatment on disability after a first clinical event suggestive of multiple sclerosis: a 3-year follow-up analysis of the BENEFIT study , 2007, The Lancet.
[31] C. Polman,et al. Infratentorial lesions predict long-term disability in patients with initial findings suggestive of multiple sclerosis. , 2004, Archives of neurology.
[32] G. Comi,et al. Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. , 1997, Brain : a journal of neurology.
[33] Jeffrey A. Cohen,et al. Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria , 2011, Annals of neurology.
[34] À. Rovira,et al. Baseline MRI predicts future attacks and disability in clinically isolated syndromes , 2006, Neurology.
[35] Jonathan Taylor,et al. Statistical mapping analysis of lesion location and neurological disability in multiple sclerosis: application to 452 patient data sets , 2003, NeuroImage.
[36] F. Barkhof,et al. Clinical correlations of brain lesion distribution in multiple sclerosis , 2009, Journal of magnetic resonance imaging : JMRI.
[37] A. Janssens,et al. Callosal lesion predicts future attacks after clinically isolated syndrome , 2009, Neurology.
[38] M. Deloire,et al. Predictive factors for multiple sclerosis in patients with clinically isolated spinal cord syndrome , 2011, Multiple sclerosis.
[39] Giuseppe Scotti,et al. The topographical distribution of tissue injury in benign MS: A 3T multiparametric MRI study , 2008, NeuroImage.
[40] David H. Miller,et al. Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial , 2009, The Lancet Neurology.
[41] B. Brownell,et al. The distribution of plaques in the cerebrum in multiple sclerosis , 1962, Journal of neurology, neurosurgery, and psychiatry.